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RESOURCES FOR NEUROGENETICS RESEARCH
NINDS Human Genetics Resource Center.—The Na-
tional Institute of Neurological Disorders and Stroke
(NINDS) is committed to gene discovery as a strategy
for identifying the genetic causes and correlates of ner-
vous system disorders. The NINDS Human Genetics Re-
source Center (http://ccr.coriell.org/ninds/) at the Coriell
Institute for Medical Research is a repository of DNA
samples, immortalized cell lines, and accompanying clin-
ical data for a set of disorders (including stroke, Par-
kinson disease, epilepsy, and motor neuron disease). The
resources include cell lines and DNA derived from af-
fected and unaffected blood relatives, spousal controls,
and other normal healthy individuals. Data for each dis-
ease are collected using standardized instruments and
are deﬁned in clinical diagnostic elements (CDEs), which
are based on published diagnostic criteria for these dis-
orders. For example, the CDEs for Parkinson disease
were designed to reﬂect the widely utilized London Brain
Bank Criteria in a format designed for easy use in the
clinic or ﬁeld. To date, the repository has 1600 samples
available, including samples from 1300 individuals with
Parkinson disease and 95 unaffected blood relatives, as
well as samples from 22 individuals with epilepsy and
13 unaffected blood relatives. Additionally, there are
1150 samples from controls for whom family and med-
ical histories and mental-status and neurological-ex-
amination data are available. The cell lines and DNA
derived from them are available to all qualiﬁed inves-
tigators. Information about ordering cell lines and DNA
samples can be obtained from the NINDS Cell and DNA
Repository Catalog Web site (http://ccr.coriell.org/ninds/
comm/order/order.html). Further information can be ob-
tained from Jeanne C. Beck, Ph.D., Coriell Institute for
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Medical Research, Coriell Cell Repositories, 403 Had-
don Avenue, Camden, NJ 08103; telephone: (800) 752-
3805; e-mail: jbeck@umdnj.edu
CALL FOR PROPOSALS
Angelman Syndrome Foundation Call for Proposals.—
The Angelman Syndrome Foundation announces the
availability of $200,000 to be awarded in support of
research on Angelman syndrome. Angelman syndrome
is a neurodevelopmental disorder caused by a deﬁciency
of the ubiquitin protein ligase UBE3A in the brain. Ap-
plications related to any area of research involving An-
gelman syndrome will be considered; the highest priority
will be given to pilot projects to test new ideas about
the pathogenesis of and the therapy for Angelman syn-
drome. Researchers from all countries are encouraged
to apply. One-year grants will be awarded for amounts
of up to $80,000. The application should include the
following: a one-page summary; a proposal of up to ﬁve
pages, including hypothesis, background, methods, and
signiﬁcance of the proposed research; a one-page de-
tailed budget; and a curriculum vitae of the applicant.
No indirect costs will be allowed. Proposals involving
human or animal subjects must be approved by insti-
tutional review boards before funding is released. The
application deadline is January 15, 2005. Applications
should be submitted to the Angelman Syndrome Foun-
dation, 3015 East New York Street, Suite A2265, Au-
rora, IL 60504. Questions about this announcement
should be directed to Joseph Wagstaff, M.D., Ph.D.;
telephone: (704) 355-6091; e-mail: joseph.wagstaff@
carolinashealthcare.org
EMPLOYMENT OPPORTUNITIES
Combined Residency in Internal Medicine and Medi-
cal Genetics.—The University of Pennsylvania School of
Medicine offers a combined, 5-year residency leading to
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eligibility for certiﬁcation by both the American Board
of Internal Medicine and the American Board ofMedical
Genetics (in clinical genetics). The training in internal
medicine occurs at the Hospital of the University of
Pennsylvania (HUP), and the training in medical genetics
occurs as a joint HUP–Children’s Hospital of Philadel-
phia genetics residency. Medical students fromU.S. med-
ical schools and students from foreign medical schools
who possess H1 or J1 American visas are encouraged
to apply. Additional information is available online (http:
//www.uphs.upenn.edu/medicine/Medicine/Applicants/
med_genetics.htm). To discuss this opportunity, contact
the ofﬁce of the program director, Reed E. Pyeritz,M.D.,
Ph.D., Maloney 538, Hospital of the University of Penn-
sylvania, 3400 Spruce Street, Philadelphia, PA 19104;
e-mail: medgenclinic@uphs.upenn.edu
Pharmacogenetics Investigator.—The Human Genetics
Group at Bristol-Myers Squibb (BMS) is focused on ap-
plying genetic approaches across different disease ar-
eas—including cardiovascular, metabolic, and psychi-
atric diseases—for the purpose of identifying novel drug
targets and markers that predict response to new ther-
apeutic drugs. We seek a pharmacogenetics investigator
who will be responsible for performing genetic studies
with the use of samples either from BMS clinical trials
or provided by collaborators (academic and biotech).
The ideal candidate will have a broad background in
human genetics, with an interest in pharmacogenetics,
and the ability to critically evaluate genetic association
studies. Qualiﬁcations include a Ph.D. (or the equiva-
lent) in genetics, epidemiology, or a related area, with
experience in generating and analyzing human genetic
data. Experience with genetic linkage/association studies
that use SNPs is desirable, as is familiarity with statistical
packages. Strong oral and written communication skills
are required, since the pharmacogenetics investigator
will be expected to interact with researchers in diverse
departments, including the drug discovery, bioinfor-
matics, biostatistics, and clinical departments. Salary is
commensurate with experience. Interested candidates
should write to Koustubh Ranade, Ph.D., Pharmaceu-
tical Research Institute, P.O. Box 5400, Princeton, NJ
08543-5400. E-mail: koustubh.ranade@bms.com
Postdoctoral Position in Genetics of Multifactorial Dis-
eases.—A full-time postdoctoral position—involving a
functional genomic approach for the study of type 2
diabetes and obesity—is available for 27 months, from
December 1, 2004, to February 28, 2007, in Lille,
France, as part of the obesity team of the Genetics of
Multifactorial Diseases Laboratory in the Department
of Human Genetics of the Institut de Biologie de Lille
(CNRS UMR 8090) (director of the unit: Professor Phi-
lippe Froguel). The project involves a functional geno-
mic approach for studying genes from cannabinoid sig-
naling, as well as functional studies to validate SNPs
involved in the modulation of food intake and/or
gluco-lipidic metabolism. Responsibilities include the
functional analysis of SNPs (studying their effects on
promoter activity, mRNA stability, and alternative splic-
ing, as well as examining codingmutations,mutagenesis,
and expression in cellular lines) and the application of
siRNA andmicroarrays. The individual selectedwill also
be responsible for the setup of microarray technology.
Candidates should have excellent experience in molec-
ular biology, as well as in RNA and microarray tech-
nologies. Experience with animal models would be ap-
preciated. Requirements include a Ph.D. in the biological
sciences and at least 3 years in a postdoctoral position
in the ﬁeld of genetics of multifactorial diseases. Appli-
cations will be reviewed from October 2004 until a suit-
able candidate is identiﬁed. Interviews may begin in late
October. Interested applicants should submit a letter of
intent, a summary of previous research experience, a
curriculum vitae, and the names of three references to
Philippe Boutin (post-doc@mail-good.pasteur-lille).
Postdoctoral Position in Genetics of Multifactorial Dis-
eases.—A full-time postdoctoral position—involving a
functional genomic approach for the study of type 2
diabetes and obesity—is available for 27 months, from
December 1, 2004, to February 28, 2007, in Lille,
France, as part of the obesity team of the Genetics of
Multifactorial Diseases Laboratory in the Department
of Human Genetics of the Institut de Biologie de Lille
(CNRS UMR 8090) (director of the unit: Professor Phi-
lippe Froguel). The project involves genetic epidemiol-
ogy studies of genes involved in cannabinoid signaling,
examination of their contribution to genetic risk for di-
abetes and obesity, and investigation of their interaction
with pathways regulated by CART, ACRP30/adiponec-
tin, and ghrelin. Responsibilities include (1) supervision
of candidate-gene (biological and positional) analysis,
SNP mapping, protocol setup, selection of methodology,
and functional analysis of SNPs; (2) performance of case/
control and familial studies, haplotype studies, trans-
mission/disequilibrium tests, quantitative-trait studies,
and gene-gene interaction studies; and (3) further de-
velopment of an existing database of food-intake pa-
rameters. Candidates should have very good experience
with sequencing and genotyping technologies, as well as
with biostatistical analysis for multifactorial diseases; a
knowledge of the physiology of food intake is advan-
tageous. Applicants should be able to interact with the
biostatistics team to improve analysis tools. Require-
ments include a Ph.D. in the biological sciences and at
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least 3 years in a postdoctoral position in the ﬁeld of
genetics of multifactorial diseases. Applications will be
reviewed from October 2004 until a suitable candidate
is identiﬁed. Interviews may begin in late October. In-
terested applicants should submit a letter of intent, a
summary of previous research experience, a curriculum
vitae, and the names of three references to Philippe Bou-
tin (post-doc@mail-good.pasteur-lille).
